VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

7 hedge funds and large institutions have $3.8K invested in Viracta Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$13.4K
2 +$757
3 +$68

Top Sellers

1 -$262K
2 -$46.6K
3 -$46.2K
4
Renaissance Technologies
Renaissance Technologies
New York
-$46.1K
5
BlackRock
BlackRock
New York
-$37.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.19K
2
$860
3
$384
4
$283
5
$74
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25